Uneedle

Uneedle is a specialized medical device developer creating ultra-sharp, ultra-precise silicon microneedles for targeted drug delivery. Its lead platforms are Bella-Vue for suprachoroidal injections in ophthalmology and Bella-mu for intradermal delivery, particularly for cancer vaccines. The company leverages semiconductor manufacturing processes to produce CE-marked and FDA-approved devices, positioning itself as a co-development and manufacturing partner for pharmaceutical companies. Its technology aims to transform complex injections into reliable, in-office procedures with reduced pain and improved precision.

Proprietary silicon microneedle platform manufactured using semiconductor processes. Enables ultra-short, sharp, and precise needles for controlled-depth delivery into superficial tissues like the suprachoroidal space of the eye and the intradermal layer of the skin.

Uneedle competes in the targeted drug delivery space against other microneedle companies (using metal, polymer, or silicon), specialized ophthalmic injection device firms, and traditional syringe manufacturers. Its key differentiators are the extreme precision of its semiconductor-made silicon needles, its focus on specific anatomical spaces (suprachoroidal, intradermal), and its full in-house manufacturing control.